Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin’s lymphoma

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is still considered a definitive curative modality for refractory or relapsed non-Hodgkin’s lymphoma (NHL). However, transplant-related morbidity and mortality remain a considerable challenge. The graft-versus-host disease (GVHD)–free wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Young-Woo, Yoon, Seugyun, Min, Gi June, Park, Sung-Soo, Park, Silvia, Yoon, Jae-Ho, Lee, Sung-Eun, Cho, Byung-Sik, Eom, Ki-Seong, Kim, Yoo-Jin, Kim, Hee-Je, Lee, Seok, Min, Chang-Ki, Lee, Jong Wook, Cho, Seok-Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591200/
https://www.ncbi.nlm.nih.gov/pubmed/31089793
http://dx.doi.org/10.1007/s00277-019-03714-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591200/
https://www.ncbi.nlm.nih.gov/pubmed/31089793
http://dx.doi.org/10.1007/s00277-019-03714-x

Ejemplares similares